BCC
CHRS icon

Bridge City Capital’s Coherus Oncology CHRS Stock Holding History

Bridge City Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-367,305
Closed -$382K – 111
2024
Q3 		$382K Buy
367,305
+51,296
+16% +$70.3K 0.11% 104
2024
Q2 		$547K Buy
316,009
+625
+0.2% +$1.26K 0.18% 97
2024
Q1 		$754K Buy
315,384
+2,450
+0.8% +$6.03K 0.27% 97
2023
Q4 		$1.04M Buy
312,934
+36,710
+13% +$98.3K 0.4% 94
2023
Q3 		$1.03M Buy
276,224
+110,048
+66% +$508K 0.52% 85
2023
Q2 		$710K Buy
166,176
+90
+0.1% +$531 0.34% 92
2023
Q1 		$1.14M Sell
166,086
-636
-0.4% -$4.94K 0.57% 83
2022
Q4 		$1.32M Sell
166,722
-1,145
-0.7% -$8.81K 0.68% 75
2022
Q3 		$1.61M Buy
167,867
+5,721
+4% +$57.9K 0.89% 51
2022
Q2 		$1.17M Sell
162,146
-286
-0.2% -$2.49K 0.62% 77
2022
Q1 		$2.1M Sell
162,432
-766
-0.5% -$9.74K 0.98% 42
2021
Q4 		$2.6M Sell
163,198
-12
-0% -$210 1.07% 41
2021
Q3 		$2.62M Buy
163,210
+4,783
+3% +$70.1K 1.19% 33
2021
Q2 		$2.19M Sell
158,427
-5,602
-3% -$79.3K 0.75% 68
2021
Q1 		$2.4M Buy
164,029
+46,298
+39% +$786K 0.79% 64
2020
Q4 		$2.05M Sell
117,731
-1,224
-1% -$21.8K 0.78% 64
2020
Q3 		$2.18M Buy
+118,955
New +$2.21M 1.04% 48

Other funds holding CHRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Bridge City Capital's CHRS Position: Q4 2024 in Review

Bridge City Capital sold out of Coherus Oncology (CHRS) in Q4 2024, closing a stake of 367,305 shares — an estimated $382K sold.

Bridge City Capital first reported a position in CHRS in Q3 2020 and held it in 17 quarters. The position peaked at $2.62M in Q3 2021. 124 funds tracked by Wall St. Rank hold CHRS as of Q4 2024.

  • Bridge City Capital reported no remaining Coherus Oncology position as of Q4 2024 after selling out during the quarter.
  • Bridge City Capital sold 367,305 Coherus Oncology shares in Q4 2024, an estimated $382K.
  • Bridge City Capital first reported a position in Coherus Oncology in Q3 2020 and held it in 17 quarters.
  • Bridge City Capital's Coherus Oncology position peaked at $2.62M in Q3 2021.
  • 124 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2024.

Based on Bridge City Capital's 13F filing for Q4 2024, filed 11 Feb 2025.